Abstract
Background: Organ dysfunctions and medical complications, such as renal failure, liver impairment, coagulation disorders, cardiovascular and respiratory illnesses, may hamper an adequate pain management in haematological patients.
Aim: To summarize current knowledge on pain management in hematological patients presenting major organ dysfunctions and comorbidity. We also attempted to provide recommendations to optimize analgesia and to minimize side effects in the setting of medically compromised and frail haematological patients.
Methods: A systematic search of the literature, using relevant key words, was conducted in PubMed.
Results and conclusions: Pain in hematological patients is a common symptom and is often multi-factorial. Most pharmacotherapeutic measures, including causal therapies, analgesics and adjuvant agents routinely applied in pain management, may also be used in the setting of clinical frailty and medical comorbidities; however, comprehensive clinical and functional patient’s evaluations and a careful consideration of expected benefits and potential adverse events are required.
Keywords: Analgesics, anticoagulant oral therapy, blood diseases, cardiovascular diseases, chronic illnesses, coagulation defects, haematology, heparin, liver dysfunctions, liver cirrhosis, liver failure, medical complications, non steroidal antiinflammatory drugs (NSAIDs), opioids, oral anticoagulant therapy, pain, pain management, paracetamol, renal impairment, thrombocytopenia
Cardiovascular & Hematological Agents in Medicinal Chemistry
Title:Pain Management in Hematological Patients with Major Organ Dysfunctions and Comorbid Illnesses
Volume: 10 Issue: 2
Author(s): Pasquale Niscola, Andrea Tendas, Marco Giovannini, Laura Scaramucci, Luca Cupelli, Michele Ferrannini, Gregorio Antonio Brunetti, Francesco Bondanini, Roberto Palumbo, Alessio Perrotti, Claudio Romani, Claudio Cartoni, Fabio Efficace and Paolo de Fabritiis
Affiliation:
Keywords: Analgesics, anticoagulant oral therapy, blood diseases, cardiovascular diseases, chronic illnesses, coagulation defects, haematology, heparin, liver dysfunctions, liver cirrhosis, liver failure, medical complications, non steroidal antiinflammatory drugs (NSAIDs), opioids, oral anticoagulant therapy, pain, pain management, paracetamol, renal impairment, thrombocytopenia
Abstract: Background: Organ dysfunctions and medical complications, such as renal failure, liver impairment, coagulation disorders, cardiovascular and respiratory illnesses, may hamper an adequate pain management in haematological patients.
Aim: To summarize current knowledge on pain management in hematological patients presenting major organ dysfunctions and comorbidity. We also attempted to provide recommendations to optimize analgesia and to minimize side effects in the setting of medically compromised and frail haematological patients.
Methods: A systematic search of the literature, using relevant key words, was conducted in PubMed.
Results and conclusions: Pain in hematological patients is a common symptom and is often multi-factorial. Most pharmacotherapeutic measures, including causal therapies, analgesics and adjuvant agents routinely applied in pain management, may also be used in the setting of clinical frailty and medical comorbidities; however, comprehensive clinical and functional patient’s evaluations and a careful consideration of expected benefits and potential adverse events are required.
Export Options
About this article
Cite this article as:
Niscola Pasquale, Tendas Andrea, Giovannini Marco, Scaramucci Laura, Cupelli Luca, Ferrannini Michele, Antonio Brunetti Gregorio, Bondanini Francesco, Palumbo Roberto, Perrotti Alessio, Romani Claudio, Cartoni Claudio, Efficace Fabio and de Fabritiis Paolo, Pain Management in Hematological Patients with Major Organ Dysfunctions and Comorbid Illnesses, Cardiovascular & Hematological Agents in Medicinal Chemistry 2012; 10 (2) . https://dx.doi.org/10.2174/187152512800388902
DOI https://dx.doi.org/10.2174/187152512800388902 |
Print ISSN 1871-5257 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6182 |
Call for Papers in Thematic Issues
Medicinal Plants with Beneficial Properties on Diabetes and Hypertension
Diabetes and hypertension are real scourges of the 21st century. It is imperative to act in order to find innovative solutions to this problem. Taking medications such as hypoglycemic and antihypertensive drugs may aggravate certain underlying comorbidities, such as chronic kidney disease and cardiovascular disease. This significant drawback therefore requires ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Current Evidence and Future Perspectives on Anti-platelet and Statin Pharmacotherapy for Patients with Symptomatic Peripheral Arterial Disease
Current Vascular Pharmacology Dietary Nitrite in Nitric Oxide Biology: A Redox Interplay with Implications for Pathophysiology and Therapeutics
Current Drug Targets Antithrombotic Treatment in the Prevention of Ischemic Stroke
Current Drug Targets Role of Antioxidants, Essential Fatty Acids, Carnitine, Vitamins, Phytochemicals and Trace Elements in the Treatment of Diabetes Mellitus and its Chronic Complications
Endocrine, Metabolic & Immune Disorders - Drug Targets Regulation of Angiotensin II Receptor Expression
Current Pharmaceutical Design A Review of Patents on Implantable Heart-Compression/Assist Devices and Systems
Recent Patents on Biomedical Engineering (Discontinued) Controversies of Dopamine Agonists: Somnolence, Cardiac Valvulopathy and Repetitive Behaviors
Current Drug Therapy Roles of Insulin Resistance, Endothelial Dysfunction and Lifestyle Changes in the Development of Cardiovascular Disease in Diabetic Patients
Current Drug Targets Apolipoprotein A-I Mimetic Peptides for the Treatment of Coronary Artery Disease
Current Cardiology Reviews Editorial [Hot topic: Modifying Cardiovascular Risk Factors: Epidemiology and Characteristics of Smoking-Related Cardiovascular Diseases (Executive Editor: Aurelio Leone)]
Current Pharmaceutical Design ATP Non-Competitive Ser/Thr Kinase Inhibitors as Potential Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry Markers of Atherosclerotic Disease: What do they Mean? Current Opinion and Future Trends
Current Pharmaceutical Design Hypertension and Ischemic Heart Disease in Women
Current Pharmaceutical Design Erythropoietin and Oxidative Stress
Current Neurovascular Research Recent Patents on Polymeric Scaffolds for Tissue Engineering
Recent Patents on Biomedical Engineering (Discontinued) Atrial Macroreentry in Congenital Heart Disease
Current Cardiology Reviews Antithrombotic Treatment in Diabetes Mellitus: A Review of the Literature about Antiplatelet and Anticoagulation Strategies Used for Diabetic Patients in Primary and Secondary Prevention
Current Pharmaceutical Design Targeting Metabolic Enzymes in Cancer – Clinical Trials Update
Current Enzyme Inhibition Coronary Microcirculation in Heart Failure with Preserved Systolic Function
Current Pharmaceutical Design Targeting Cyclooxygenase and Nitric Oxide Pathway Cross-Talk: A New Signal Transduction Pathway for Developing More Effective Anti- Inflammatory Drugs
Current Signal Transduction Therapy